| Okawa Y, Aiba K
[Molecular-targeted drugs. 1) Indications and the application of molecular-targeted drugs in hematological diseases] [Journal Article, Review]
Nippon Naika Gakkai Zasshi 2009 Aug 10; 98(8):1908-17.
Full Citation | Find Related Articles |
| Jazieh AR, Komrokji R, Gupta A, et al.
Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer. [Journal Article]
Cancer Invest 2009 Nov; 27(9):932-6.
Abstract | Full Citation | Find Related Articles |
| Almadi M, Ghali PM, Constantin A, et al.
Recurrent obscure gastrointestinal bleeding: Dilemmas and success with pharmacological therapies. Case series and review. [Journal Article]
Can J Gastroenterol 2009 Sep; 23(9):625-31.
Abstract | Full Citation | Find Related Articles |
| Ravikumar K, Sridhar B
Lenalidomide, an antineoplastic drug, and its hemihydrate. [Journal Article]
Acta Crystallogr C 2009 Oct; 65(Pt 10):o502-5.
Abstract | Full Citation | Publisher Full Text |
| Lee SM, Rudd R, Woll PJ, et al.
Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Oct 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Bauditz J
[Angiogenesis inhibitors for treatment of angiodysplasia-related gastrointestinal bleeding] [Journal Article, Review]
Dtsch Med Wochenschr 2009 Sep; 134(38):1893-6.
Full Citation | Publisher Full Text | Find Related Articles |
| Layzer R, Wolf J
Myeloma-associated polyneuropathy responding to lenalidomide. [Case Reports, Journal Article]
Neurology 2009 Sep 8; 73(10):812-3.
Full Citation | Publisher Full Text | Find Related Articles |
| Escoubet-Lozach L, Lin IL, Jensen-Pergakes K, et al.
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism. [Journal Article]
Cancer Res 2009 Sep 15; 69(18):7347-56.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Neymotin A, Petri S, Calingasan NY, et al.
Lenalidomide (Revlimid(R)) Administration at Symptom Onset is Neuroprotective in a Mouse Model of Amyotrophic Lateral Sclerosis. [JOURNAL ARTICLE]
Exp Neurol 2009 Sep 3.
Abstract | Full Citation |
| Scott BL
Clinical roundtable monograph. Combination therapies for MDS. [Journal Article]
Clin Adv Hematol Oncol 2009 Jul; 7(7):S13-5.
Full Citation | Find Related Articles |
  |
